GLP-1 agonist drugs play several roles in the bodyincluding improving diabetes outcomes and stimulating weight loss
Who injections are better for: People who want evidence-based, FDA-approved therapy Those eligible for insurance reimbursement Patients with diabetes or cardiovascular risks Anyone prioritizing consistent, measurable results Who patches may appeal to: People afraid of needles Curious biohackers who want to try supplements rather than true GLP-1s Those willing to experiment with their health Expert Opinion C
Arvind Venkat (D., Allegheny), also an active emergency physician, told Spotlight PA
Early GHK-Cu peptide results look most promising when it is combined with therapies like PRP, exosomes, or low-level laser in carefully selected patients
This enables reproducible peptide reconstitution across multiple experimental sessions from a single preparation
Furthermore, the production of nucleotides supports the replenishment of the oxidized nucleotide pool and facilitates DNA repair